Pearls and pitfalls in the intensive care management of Guillain-Barré syndrome

Seminars in Neurology

Volumn 21, Issue 4, 2001, Pages 399-405

  Chalela, J A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Complications; Guillain Barr syndrome; Intensive care; Management; Neuromuscular respiratory failure

Indexed keywords

ANALGESIA; ANAMNESIS; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL FEATURE; DYSAUTONOMIA; GUILLAIN BARRE SYNDROME; HOSPITAL ADMISSION; HUMAN; IATROGENIC DISEASE; INTENSIVE CARE; NUTRITION; PATIENT POSITIONING; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY FAILURE; TRACHEOSTOMY;

GUILLAIN-BARRE SYNDROME; HUMANS; INTENSIVE CARE; PROGNOSIS; RECOVERY OF FUNCTION;

EID: 0035659835     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-19411     Document Type: Article

References (19)

1. Guillain-Barré syndrome
2. Ventilatory management in critical neurologic illness
3. General care
4. Guillain-Barré syndrome
5. Intravenous immunoglobulin treatment in peripheral nerve disorders: Indications, mechanisms of action and side effects
6. Pain in Guillain-Barré syndrome
7. Hypermetabolism and hypercatabolism in Guillain-Barré syndrome
8. Clinical features of the typical syndrome
9. The doctor as a patient: An encounter with Guillain-Barré syndrome
10. Carbamazepine for pain management in Guillain-Barré syndrome patients in the intensive care unit
11. Autonomic dysfunction in experimental autoimmune neuritis
12. Skin sympathetic nerve activity in Guillain-Barré syndrome: A microneurographic study
13. Guillain-Barré syndrome
14. Intravenous immunoglobulin treatment of neurological autoimmune diseases
15. Characteristics of 73 patients, 1984-1973, treated by plasma exchange for Guillain-Barré syndrome
16. Acute motor axonal neuropathy and acute motor-sensory axonal neuropathy share a common immunological profile
17. Long-term outcome in patients with Guillain-Barré syndrome requiring mechanical ventilation
18. Prognostic factors of Guillain-Barré syndrome after intravenous immunoglobulin or plasma exchange
19. Prognostic value of cerebrospinal fluid neuron-specific enolase and S-100b protein in Guillain-Barré syndrome